Correlation Between Clearside Biomedical and Apimeds Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Clearside Biomedical and Apimeds Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearside Biomedical and Apimeds Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clearside Biomedical and Apimeds Pharmaceuticals US,, you can compare the effects of market volatilities on Clearside Biomedical and Apimeds Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearside Biomedical with a short position of Apimeds Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearside Biomedical and Apimeds Pharmaceuticals.

Diversification Opportunities for Clearside Biomedical and Apimeds Pharmaceuticals

-0.35

Correlation Coefficient

Clearside Biomedical  Apimeds Pharmaceuticals

Very good diversification

The 3 months correlation between Clearside and Apimeds is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Clearside Biomedical and Apimeds Pharmaceuticals US, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apimeds Pharmaceuticals and Clearside Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearside Biomedical are associated (or correlated) with Apimeds Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apimeds Pharmaceuticals has no effect on the direction of Clearside Biomedical i.e., Clearside Biomedical and Apimeds Pharmaceuticals go up and down completely randomly.

Pair Corralation between Clearside Biomedical and Apimeds Pharmaceuticals

Given the investment horizon of 90 days Clearside Biomedical is expected to under-perform the Apimeds Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Clearside Biomedical is 1.11 times less risky than Apimeds Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The Apimeds Pharmaceuticals US, is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  167.00  in Apimeds Pharmaceuticals US, on August 5, 2025 and sell it today you would earn a total of  52.00  from holding Apimeds Pharmaceuticals US, or generate 31.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Clearside Biomedical  vs.  Apimeds Pharmaceuticals US,

Clearside Biomedical

Risk-Adjusted Performance

Weakest

Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Apimeds Pharmaceuticals

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Apimeds Pharmaceuticals US, are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Apimeds Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Clearside Biomedical and Apimeds Pharmaceuticals

The main advantage of trading using opposite Clearside Biomedical and Apimeds Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearside Biomedical position performs unexpectedly, Apimeds Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apimeds Pharmaceuticals will offset losses from the drop in Apimeds Pharmaceuticals' long position.

The idea behind Clearside Biomedical and Apimeds Pharmaceuticals US, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.